Regeneron Pharmaceuticals, Inc. (REGN)

Historical Portfolio Holders from 2014 to 2024

All holders as of
Q1 2024
Type / Class
Equity / COM
Shares, Excl. Options Q1 2024
$89.3M
Holdings value Q1 2024
$85.8B
Value change Q1 2024
+$1.15B
Grand Portfolio weight change Q1 2024
+0.002%
Number of holders
1310
Number of Buys Q1 2024
568
Number of Sells Q1 2024
-513
Average Buys Q1 2024 %
+0.014%
Average Sells Q1 2024 %
-0.008%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Filings
Period Shares, Excl. Options Value, Excl. Options Change Price Filings
2024 Q1 89.2M $85.8B +$1.21B $962.49 1,283
2023 Q4 89.9M $79B +$1.05B $878.29 1,293
2023 Q3 89.7M $73.9B -$555M $822.96 1,205
2023 Q2 90.8M $65.3B -$1.69B $718.54 1,195
2023 Q1 93.3M $75B -$760M $821.67 1,216
2022 Q4 94M $67B -$137M $721.49 1,187
2022 Q3 92.7M $63.9B +$32.2M $688.87 1,114
2022 Q2 93M $54.9B +$1.05B $591.13 1,093
2022 Q1 92.3M $64.4B +$1.65B $698.42 1,129
2021 Q4 90.1M $56.8B +$293M $631.52 1,113
2021 Q3 90.2M $54.4B +$1.12B $605.18 1,046
2021 Q2 88.8M $49.5B -$202M $558.54 1,001
2021 Q1 89.4M $42.2B +$852M $473.14 944
2020 Q4 90.2M $43.5B +$16.1M $483.11 935
2020 Q3 91.9M $51.5B +$164M $559.78 946
2020 Q2 92.5M $57.7B +$10.8B $623.65 964
2020 Q1 75.6M $36.8B +$1.34B $488.29 854
2019 Q4 73.8M $27.7B +$467M $375.48 737
2019 Q3 73.6M $20.4B +$248M $277.40 667
2019 Q2 73.6M $23B +$640M $313.00 705
2019 Q1 73.9M $30.3B +$772M $410.62 760
2018 Q4 73.1M $27.3B -$94.3M $373.50 715
2018 Q3 73.6M $29.7B +$596M $404.04 690
2018 Q2 72.6M $25B +$498M $344.99 668
2018 Q1 72.3M $24.9B +$903M $344.36 671
2017 Q4 71.5M $26.9B -$254M $375.96 691
2017 Q3 72.4M $32.3B -$32.8M $447.12 663
2017 Q2 73.1M $35.9B +$1.45B $491.14 657
2017 Q1 71.9M $27.9B +$2.52B $387.51 632
2016 Q4 71.8M $26.3B -$508M $367.09 633
2016 Q3 73.6M $29.2B +$736M $402.02 605
2016 Q2 72.5M $25B -$2.58B $349.23 591
2016 Q1 79.7M $26.2B +$87M $360.44 588
2015 Q4 73.2M $39.7B +$25M $542.87 622
2015 Q3 73.3M $34.1B -$83.2M $465.14 598
2015 Q2 73.8M $37.2B +$606M $510.13 576
2015 Q1 73M $32.9B +$601M $451.48 535
2014 Q4 72.1M $29.6B +$728M $410.25 550
2014 Q3 71.6M $27.9B +$625M $360.52 501
2014 Q2 73.5M $20.7B +$139M $282.47 473
2014 Q1 73.5M $22B -$629M $300.28 479